L. Miron
M. Pirciu
Benefits of early treatment with Zytiga in newly diagnosed high risk mHSPC
M. Marinca
Ce opțiuni de tratament avem în CRPC?
Diana Petroiu
Xtandi Win Time Prevail data I
M. Marinca
Xtandi Win Time Prevail data II
Diana Petroiu
Patient Case
B. Gafton